Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
In BriefThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine August 2011, 52 (8) 10A-11A;
  • Article
  • Info & Metrics
  • PDF
Loading

Cardiac neuronal imaging: Bengel focuses on basic methodologic aspects of and challenges in the translation of targeted imaging of the sympathetic nervous system from research tools to routine clinical applications.Page 1167

Reviving antibody imaging: Boerman and Oyen provide an overview of immuno-PET and its applications in patient management, dose calculation in radioimmunotherapy, and development of antibody-based drugs and preview a related article in this issue of JNM.Page 1171

124I-huA33-antibody PET: Carrasquillo and colleagues use quantitative PET to evaluate the biodistribution and other in vivo attributes of a humanized monoclonal antibody with implications for imaging and treatment of colorectal cancer.Page 1173

Figure

18F-FLT PET in lung cancer: Brockenbrough and colleagues describe relationships among static/dynamic analysis parameters of 18F-FLT PET, expression of the proliferation marker Ki-67, and protein expression and enzymatic activity of thymidine kinase-1 in resected lung lesions.Page 1181

Personalizing PET-guided therapy: Meyer zum Büschenfelde and colleagues report on the use of salvage neoadjuvant radiochemotherapy to improve outcomes in patients with adenocarcinomas of the esophagus identified on 18F-FDG PET as likely to respond poorly to conventional preoperative chemotherapy.Page 1189

Bone mets after PRRT: Ezziddin and colleagues look at response and long-term control of bone metastases from gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.Page 1197

Figure

Lower-dose MPI: Nkoulou and colleagues determine whether accurate assessment of ischemic myocardial disease is feasible with a low-dose/low-dose 1-d SPECT myocardial perfusion imaging protocol using a cadmium zinc telluride device.Page 1204

Figure

18F-florbetaben in dementia: Villemagne and colleagues use 18F-florbetaben PET to compare cortical amyloid deposition in controls and in individuals with mild cognitive impairment, frontotemporal lobar degeneration, dementia with Lewy bodies, vascular dementia, Parkinson disease, and Alzheimer disease.Page 1210

Figure

PET score for Alzheimer progression: Herholz and colleagues evaluate the utility of a predefined quantitative measure extracted from 18F-FDG PET imaging as a valid biomarker to monitor progression of mild cognitive impairment to Alzheimer disease.Page 1218

Multimodal neuroimaging in gliomas: Stadlbauer and colleagues investigate and categorize peritumoral fiber tract alterations according to changes in metabolism and integrity of fiber structures using 18F-fluoroethyl tyrosine PET and diffusion tensor imaging in patients with cerebral gliomas.Page 1227

Microglial activation after TBI: Folkersma and colleagues assess (R)-11C-PK11195 binding as an indirect marker of neuronal damage after traumatic brain injury.Page 1235

Figure

Radiation risk in children: Fahey and colleagues provide an overview of radiation dosimetry for radiopharmaceuticals and CT, radiation risk estimation in pediatric nuclear medicine, approaches for communication of risk to patients’ families, and radiation dose reduction strategies.Page 1240

Extracerebral reference tissue in rats: Backes and colleagues describe a kinetic modeling approach in which PET-assessed glucose metabolism of the whiskers area of the rat can provide quantitative noninvasive determination of cerebral glucose consumption.Page 1252

PET and response to crizotinib: Cullinane and colleagues report on PET imaging of glucose metabolism and cell proliferation to monitor tumor response to crizotinib, an adenosine triphosphate–competitive c-MET kinase inhibitor, in cell lines with aberrant c-MET signaling.Page 1261

Integrated PET and optical 3D: Li and colleagues detail the development and evaluation of a simultaneous PET and 3-dimensional fluorescence optical tomography system for small-animal imaging.Page 1268

Figure

64Cu- and 68Ga-RGDs for PET: Dumont and colleagues describe novel radiolabeling and initial studies with arginine-glycine-aspartic acid peptides, with promise for visualizing and quantifying ανβ3 integrin expression.Page 1276

Figure

Multiplexed multipinhole SPECT: Strydhorst and colleagues evaluate innovative instrumentation for reproducible measurements of serial left ventricle perfusion, volume, and ejection fraction in myocardial infarcted and healthy rats.Page 1285

A1R imaging: Paul and colleagues determine whether 11C-MPDX PET can be used for quantitative studies of cerebral adenosine A1 receptors in rat brain and discuss techniques that may enhance the information provided.Page 1293

Figure

Radiolabeled imatinib analog: Glekas and colleagues report on the synthesis of an 18F-labeled analog of imatinib to be used to assess in vivo drug distribution and tracer concentration and as a PET imaging surrogate for imatinib.Page 1301

Figure

PET/MRI and nerve injury: Behera and colleagues explore the potential for hybrid 18F-FDG PET/MRI assessment of injured peripheral nerves in a small-animal model of neuropathic pain.Page 1308

Figure

18F-LBT-999 bioassessment: Varrone and colleagues evaluate the quantification, biodistribution, and radiation dosimetry of a novel dopamine transporter radioligand in nonhuman primates.Page 1313

Figure

Clinical 11C-4DST PET: Toyohara and colleagues describe safety, distribution, radiation dosimetry, and initial brain tumor imaging with this in vivo cell proliferation marker in humans.Page 1322

Figure

ON THE COVER

A multimodal neuroimaging approach described in this issue provides complementary information on peritumoral fiber tract alterations in gliomas that may be helpful for planning treatment and predicting prognosis. In the 3 patients illustrated here, peritumoral fibers were of identical metabolic category but were shown by the new approach to be of 3 different structural types: compressed, normal, or attenuated.See page 1230.

Figure
  • © 2011 by Society of Nuclear Medicine
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 52 (8)
Journal of Nuclear Medicine
Vol. 52, Issue 8
August 1, 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Aug 2011, 52 (8) 10A-11A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Aug 2011, 52 (8) 10A-11A;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • ON THE COVER
  • Info & Metrics
  • PDF

Related Articles

  • Classification of Peritumoral Fiber Tract Alterations in Gliomas Using Metabolic and Structural Neuroimaging
  • Tumor 3′-Deoxy-3′-18F-Fluorothymidine (18F-FLT) Uptake by PET Correlates with Thymidine Kinase 1 Expression: Static and Kinetic Analysis of 18F-FLT PET Studies in Lung Tumors
  • Response and Long-Term Control of Bone Metastases After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
  • Immuno-PET of Cancer: A Revival of Antibody Imaging
  • 18F-FDG PET–Guided Salvage Neoadjuvant Radiochemotherapy of Adenocarcinoma of the Esophagogastric Junction: The MUNICON II Trial
  • Reproducibility of Serial Left Ventricle Perfusion, Volume, and Ejection Fraction Measurements Using Multiplexed Multipinhole SPECT in Healthy Rats and Rats After Myocardial Infarction
  • Novel 64Cu- and 68Ga-Labeled RGD Conjugates Show Improved PET Imaging of ανβ3 Integrin Expression and Facile Radiosynthesis
  • Evaluation of a Calibrated 18F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment
  • Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias
  • In Vivo Imaging of Bcr-Abl Overexpressing Tumors with a Radiolabeled Imatinib Analog as an Imaging Surrogate for Imatinib
  • Minimizing and Communicating Radiation Risk in Pediatric Nuclear Medicine
  • Widespread and Prolonged Increase in (R)-11C-PK11195 Binding After Traumatic Brain Injury
  • Small-Animal PET Study of Adenosine A1 Receptors in Rat Brain: Blocking Receptors and Raising Extracellular Adenosine
  • 18F-FDG PET/MRI Can Be Used to Identify Injured Peripheral Nerves in a Model of Neuropathic Pain
  • Differential 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET Responses to Pharmacologic Inhibition of the c-MET Receptor in Preclinical Tumor Models
  • Whole-Body Distribution and Brain Tumor Imaging with 11C-4DST: A Pilot Study
  • Whiskers Area as Extracerebral Reference Tissue for Quantification of Rat Brain Metabolism Using 18F-FDG PET: Application to Focal Cerebral Ischemia
  • Imaging Targets of the Sympathetic Nervous System of the Heart: Translational Considerations
  • Simultaneous PET and Multispectral 3-Dimensional Fluorescence Optical Tomography Imaging System
  • 124I-huA33 Antibody PET of Colorectal Cancer
  • Imaging of the Striatal and Extrastriatal Dopamine Transporter with 18F-LBT-999: Quantification, Biodistribution, and Radiation Dosimetry in Nonhuman Primates
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire